Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma

Published:2023-02-01 Issue:4 Volume:136 Page:485-487
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Liu Jifeng¹²,Yuan Qihang³,Ren Jie⁴,Li Yiming⁵,Zhang Yunshu⁶,Shang Dong¹²

Affiliation:

1. Department of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China

2. Department of Clinical Laboratory of Integrative Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China

3. Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning 116011, China

4. Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011 China

5. Department of NHC Key Laboratory of Antibiotic Bioengineering, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China

6. Department of Traditional Chinese Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference5 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. A global view of hepatocellular carcinoma: trends, risk, prevention, and management;Yang;Nat Rev Gastroenterol Hepatol,2019

3. Single-cell RNA sequencing in cardiovascular development, disease and medicine;Paik;Nat Rev Cardiol,2020

4. Immunological microenvironment predicts the survival of the patients with hepatocellular carcinoma treated with anti-PD-1 antibody;Morita;Liver Cancer,2021

5. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic;Chan;Ann Oncol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing;Frontiers in Immunology;2024-09-13

2. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer;Journal of Translational Medicine;2024-06-10

3. Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis;Lipids in Health and Disease;2024-01-02

4. Development of an RNA modification writer-related lncRNA signature to predict prognosis, tumor microenvironment, and treatment outcome for hepatocellular carcinoma;Asian Journal of Surgery;2024-01

5. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study;Journal of Translational Medicine;2023-11-30